https://biotechmorning.com/news/zipalertinib-egfr-exon20-lung-cancer-challenge Biotech Morning en 2026-09-14T14:19:03.003Z The Pill That's Coming for J&J's Lung Cancer Throne https://biotechmorning.com/news/electra-therapeutics-billion-dollar-ipo-sirp Biotech Morning en 2026-09-14T14:18:15.600Z A Billion-Dollar Bet on a Protein Most People Have Never Heard Of https://biotechmorning.com/news/cellectis-abandons-allogeneic-car-t-pivots-in-vivo Biotech Morning en 2026-09-14T14:17:34.200Z The Company That Pioneered Off-the-Shelf CAR-T Just Walked Away From It https://biotechmorning.com/news/jj-amivantamab-papillon-os-catch Biotech Morning en 2026-09-14T14:16:45.332Z J&J Says This Lung Cancer Combo Delivers Nearly 3 Years of Survival. There's a Catch. https://biotechmorning.com/news/lsd-pill-three-phase-3-wins-psychedelic-medicine Biotech Morning en 2026-09-14T14:15:53.507Z An LSD Pill Just Went 3-for-3 in the Biggest Test of Psychedelic Medicine https://biotechmorning.com/news/brain-cancer-first-real-map-pixclara-fda Biotech Morning en 2026-09-14T14:15:08.366Z Brain Cancer Just Got Its First Real Map https://biotechmorning.com/news/vyriad-in-vivo-car-t-first-patient Biotech Morning en 2026-09-14T14:14:24.602Z What If Your Body Could Build Its Own Cancer-Killing Cells? https://biotechmorning.com/news/gilead-trodelvy-lung-cancer-trial-failure Biotech Morning en 2026-09-14T14:13:38.286Z Gilead's Lung Cancer Moonshot Just Crashed Back to Earth https://biotechmorning.com/news/lenacapavir-purpose-2-hiv-prevention-results Biotech Morning en 2026-09-14T14:12:42.202Z Two Shots a Year. Two Infections Out of 2,180 People. https://biotechmorning.com/news/stealth-bio-barth-syndrome-fda-approval Biotech Morning en 2026-09-14T14:11:57.684Z The Drug That Failed Its Big Test and Still Got FDA Approval https://biotechmorning.com/news/gsk-survival-bomb-lung-cancer Biotech Morning en 2026-09-13T14:19:17.279Z GSK Just Dropped a Survival Bomb on Lung Cancer's Biggest Players https://biotechmorning.com/news/fda-approves-camizestrant-after-negative-advisory-vote Biotech Morning en 2026-09-13T14:18:30.486Z The Breast Cancer Drug the FDA Said Yes to After Experts Said No https://biotechmorning.com/news/alexander-disease-first-drug-zanvastro-ionis Biotech Morning en 2026-09-13T14:17:41.814Z The Disease Nobody Could Treat Just Got Its First Drug https://biotechmorning.com/news/car-t-autoimmune-safety-crisis Biotech Morning en 2026-09-13T14:16:53.934Z CAR-T's Biggest Bet Outside Cancer Just Hit a Wall https://biotechmorning.com/news/gsk-mrna-flu-vaccine-phase-3-2 Biotech Morning en 2026-09-13T14:16:05.241Z GSK Is Betting mRNA Can Kill Its Own Cash Cow https://biotechmorning.com/news/car-t-after-car-t-failure-pepromene Biotech Morning en 2026-09-13T14:15:20.832Z A CAR-T for Patients Who Already Failed CAR-T https://biotechmorning.com/news/sarepta-black-box-warning-layoffs-gene-therapy-crisis Biotech Morning en 2026-09-13T14:14:40.540Z Sarepta's Worst Week: A Black Box, 500 Pink Slips, and a Gene Therapy in Crisis https://biotechmorning.com/news/first-drug-fixes-narcolepsy-orexin-agonist Biotech Morning en 2026-09-13T14:13:54.055Z The First Drug That Actually Fixes What's Broken in Narcolepsy https://biotechmorning.com/news/tam-peli-sclc-phase-3-death-risk Biotech Morning en 2026-09-13T14:13:09.416Z The Lung Cancer Drug That Cut Death Risk in Half https://biotechmorning.com/news/ivonescimab-beats-keytruda-lung-cancer Biotech Morning en 2026-09-13T14:12:19.210Z The Drug That Just Dethroned the King of Cancer